ClinicalTrials.gg
Not yet recruitingNCT07424482VID-ACSUpdated Feb 23, 2026

Educational Video to Improve Understanding and Reduce Anxiety in Heart Attack Patients

An interventional study of Educational Video in Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI), Anxiety and Patient Education Materials, sponsored by Tobias Schreiber. Not yet recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-23.

Sponsored by Tobias Schreiber · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 92 studies in Acute Coronary Syndrome with a site in Germany — 8 open to participants now, 13 under way, 1 of them phase 3. Acute Coronary Syndrome · Germany.

Planned enrollment
49th of 59
140 · median 1,861
Started
2026
with 1 other
No phase
15 of 92
4 open now
Primary completion
2027-09
later than 8 of 12 live
Registered
90th of 92
by date

Among the 92 studies in Acute Coronary Syndrome with a site in Germany, this one is the 49th largest by planned enrollment of the 59 interventional ones that give a count, is one of 2 that started in 2026, is one of 15 with no phase, reaches primary completion later than 8 of the 12 other live ones, and was the 90th registered.

Acute Coronary Syndrome

1,491 studies on the registry are indexed under Acute Coronary Syndrome; 272 are open to participants now.

Browse Acute Coronary Syndrome studies →

Open to participants now

8 of the 92 studies in Acute Coronary Syndrome with a site in Germany are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →

Who these studies take

Of the 195 Acute Coronary Syndrome studies recruiting now, 144 (74%) set no upper age limit and 19 (10%) stop at 75 or younger; 15 take children under 18; 15 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 92 studies in Acute Coronary Syndrome with a site in Germany, or all of them as a file.
02

Study summary

Patients who are diagnosed with a heart attack are often confronted with an unexpected hospital admission and an urgent heart catheterization. In this stressful situation, anxiety is common and understanding of the procedure may be limited, even after standard verbal and written explanations.

This study investigates whether a short educational video, shown in addition to standard medical information, can help patients better understand the heart catheterization procedure and reduce anxiety before the intervention. Patients will be randomly assigned to receive either standard information alone or standard information plus the educational video.

The study will assess patients' understanding of the procedure, their level of anxiety, and their satisfaction with the information provided. The results may help improve patient education and support in acute cardiac care settings.

Read the detailed description

Patients admitted with acute coronary syndrome require urgent heart catheterization under stressful and unfamiliar circumstances. Anxiety levels are often elevated, and the ability to process and retain medical information may be reduced. Standard patient education is typically provided verbally and in written form, but time constraints and the acute clinical setting may limit its effectiveness.

The purpose of this randomized controlled study is to evaluate the effect of a short, standardized educational video shown in addition to standard care. The video is designed to provide structured information about the heart catheterization procedure, including its purpose, key steps, typical visual impressions, and immediate post-procedural care, without minimizing potential risks. The intervention is intended to complement, not replace, routine physician-led informed consent.

Eligible patients with acute coronary syndrome who are undergoing heart catheterization for the first time will be enrolled and randomly assigned to either standard information alone or standard information plus the educational video.

The primary objective is to determine whether the educational video improves patients' understanding of the procedure. Secondary objectives include assessing its effect on anxiety levels and patient satisfaction.

By focusing on an easily scalable educational intervention, this study aims to provide evidence for improving patient-centered communication in acute cardiac care. If effective, the approach may be implemented into routine clinical practice.

03

Conditions studied

  • Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
  • Anxiety
  • Patient Education Materials

Keywords

  • Anxiety
  • Acute Coronary Syndrome
  • Patient Education
  • Educational Video
  • Informed Consent
  • Patient Satisfaction
  • Coronary Angiography
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • first-time Acute Coronary Syndrome
  • Diagnosis of Acute Coronary Syndrome

Exclusion criteria

Exclusion Criteria:

  • Prior heart catheterization or coronary angiography
  • Severe neurocognitive impairment that precludes valid participation in the study or
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
140 participants (estimated)

Study arms

  • No intervention
    Standard informed consent
  • Experimental
    Educational Video Plus Standard Information

    Other: Educational Video

Interventions

  • OtherEducational Video

    Participants assigned to the intervention group will receive standard verbal and written medical information according to routine clinical practice. In addition, they will watch a short, standardized educational video explaining the heart catheterization procedure, including its purpose, main steps, typical visual impressions, and immediate post-procedural care. The video is intended to complement, not replace, physician-led informed consent.

06

What researchers measure

Primary outcomes

  1. Patient knowledge

    Multiple Choice test before coronary angiography. A higher test result indicates better understanding.

    Time frame: Within 24 hours before coronary angiography

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Sep 2027, 14 months later.

Of 213 non-industry interventional studies with no phase under Acute Coronary Syndrome, half reached primary completion within 34 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 46. This study's planned 14 months is below that.

Counting every sponsor, half of 228 studies reached it within 34 months; a quarter within 17 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 9, 2026
First posted
Feb 20, 2026
StartEst.
Jul 1, 2026
Primary completionEst.
Sep 1, 2027
CompletionEst.
Apr 1, 2028
Last update
Feb 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07424482
Lead sponsor
Tobias Schreiber
Responsible party
Tobias Schreiber (Principal Investigator, Charite University, Berlin, Germany) — Sponsor-investigator
First posted
Feb 20, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Sep 1, 2027 (estimated)
Completion
Apr 1, 2028 (estimated)
Last update
Feb 23, 2026

Study contacts

Tobias Schreiber
Contact
tobias.schreiber@dhzc-charite.de
0049450513702

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion